首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal HSD3B7 Antibody

  • 中文名: HSD3B7抗体
  • 别    名: CBAS1; PFIC4; SDR11E3
货号: IPDX01458
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/200 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 1/2000-1/5000 Human,Mouse,Rat

产品详情

AliasesCBAS1; PFIC4; SDR11E3
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman, Mouse, Rat
ImmunogenFusion protein of human HSD3B7
FormulationPurified antibody in PBS with 0.05% sodium azide and 50% glycerol.

+ +

参考文献

以下是关于HSD3B7抗体的示例参考文献(注:以下内容为模拟示例,非真实存在的文献):

---

1. **文献名称**:*Role of HSD3B7 in Bile Acid Synthesis: Characterization of a Polyclonal Antibody for Enzyme Localization*

**作者**:Smith J, et al.

**摘要**:本研究开发了一种针对HSD3B7的多克隆抗体,用于检测其在肝细胞中的表达和亚细胞定位。通过免疫组化和Western blot分析,揭示了HSD3B7在胆汁酸合成途径中的关键作用,并证实其在先天性胆汁酸缺陷症患者肝组织中的表达缺失。

2. **文献名称**:*HSD3B7 Deficiency Diagnosis Using Immunohistochemical Staining*

**作者**:Lee S, et al.

**摘要**:文章报道了一种基于HSD3B7抗体的免疫染色方法,用于快速诊断先天性胆汁酸合成障碍。通过对比患者与健康对照的肝活检样本,发现HSD3B7蛋白表达显著降低,验证了该抗体在临床诊断中的实用性。

3. **文献名称**:*Development of a Monoclonal Antibody for Quantifying HSD3B7 in Serum*

**作者**:Garcia R, et al.

**摘要**:研究团队制备了一种高特异性单克隆抗体,用于ELISA法定量血清中的HSD3B7水平。该抗体在评估胆汁酸代谢紊乱患者的酶活性中表现出高敏感性和特异性,为无创诊断提供了新工具。

4. **文献名称**:*HSD3B7 Knockout Mouse Model and Antibody-Based Phenotypic Analysis*

**作者**:Wang Y, et al.

**摘要**:通过构建HSD3B7基因敲除小鼠,并利用特异性抗体进行蛋白表达分析,揭示了HSD3B7缺失导致的胆汁淤积和肝损伤表型,强调了该酶在维持胆汁酸稳态中的核心作用。

---

提示:如需真实文献,建议通过PubMed或Google Scholar以关键词“HSD3B7 antibody”“3-beta-HSD7”“bile acid synthesis”检索。

背景信息

The HSD3B7 antibody is a tool used to detect 3β-hydroxysteroid dehydrogenase type 7 (HSD3B7), an enzyme critical in bile acid biosynthesis. HSD3B7 catalyzes the oxidation and isomerization of 7α-hydroxy-cholest-4-en-3-one to 7α-hydroxy-3-oxocholest-4-en-26-oic acid, a key step in the classical pathway of bile acid synthesis. Mutations in the HSD3B7 gene cause congenital bile acid synthesis defects, leading to severe liver disorders, cholestasis, and fat-soluble vitamin deficiencies. The antibody is primarily utilized in research to study HSD3B7 expression, localization, and regulatory mechanisms in hepatic tissues and other relevant systems. It is employed in techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess protein levels in disease models, such as cholestatic liver diseases or metabolic disorders. Commercially available HSD3B7 antibodies are typically developed in rabbits or mice using synthetic peptides or recombinant protein fragments as immunogens. Validation often includes knockout controls or siRNA knockdown to confirm specificity. Recent studies also explore its role in cancer metabolism and lipid homeostasis, expanding its relevance beyond hepatology. Proper handling requires attention to tissue-specific post-translational modifications that may affect antibody binding. This tool aids in elucidating molecular pathways of bile acid metabolism and developing therapeutic strategies for related disorders.

客户数据及评论

折叠内容

大包装询价

×